NSSF Funds Lawsuit Against Virginia for Unconstitutional Firearm Bans
WASHINGTON,
"Governor
The NSSF-funded complaint, filed by
The U.S. Supreme Court's Heller decision held that firearms in common use are protected by the Second Amendment. That holding precludes bans on the legal sale of MSRs, which number over 32 million in circulation. Likewise, there are a conservatively estimated nearly 1 billion detachable magazines in private possession and hundreds of millions with a capacity exceeding 15 rounds. Many commonly owned pistols are equipped with 17-round magazines, which HB 217 / SB 749 now criminalizes. The law's expansive definition of "assault firearm" wraps in many commonly owned semiautomatic shotguns and handguns, which will be unlawful to purchase or bear in Virginia.
Additionally, because HB 217 / SB 749 bans rifles, pistols and shotguns commonly used for hunting, it violates Article XI, Section 4 of the Virginia Constitution.
About NSSF
NSSF is the trade association for the firearm industry. Its mission is to promote, protect and preserve hunting and the shooting sports. Formed in 1961, NSSF has a membership of thousands of manufacturers, distributors, firearm retailers, shooting ranges, sportsmen's organizations and publishers nationwide. For more information, visit nssf.org.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nssf-funds-lawsuit-against-virginia-for-unconstitutional-firearm-bans-302775034.html
SOURCE NATIONAL SHOOTING SPORTS FOUNDATION
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PowerBank Receives Final Environmental Permit for C$14 Million Nova Scotia Community Solar Project, Backed by C$4.55 Million in Federal and Provincial Grants and Tax Credits
- Exyn Technologies Appoints Ben Williams as Interim Chief Executive Officer and Gregory McNeal as Chairman of the Board
- Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Letter of Intent with Darmiyan, Inc. to Explore Use of FDA De Novo Authorized BrainSee(R) AI Platform in Early Alzheimer's Disease
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share